MedTrace Logo

HCV/HIV Coinfection: Antiviral Therapy and Fibrosis

NCT01423643 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1250

Last updated 2016-02-24

No results posted yet for this study

Summary

The chief purpose of this research is to understand how antiretroviral therapy (ART) affects progression of liver disease in persons co-infected with HIV and hepatitis C virus (HCV). The investigators study liver disease progression in a cohort of dually infected persons according to the success of ART.

Conditions

  • HIV Infection
  • Hepatitis C

Sponsors & Collaborators

Principal Investigators

  • David L. Thomas, MD · Johns Hopkins University

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-03-31
Primary Completion
2015-10-31
Completion
2015-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01423643 on ClinicalTrials.gov